Activation-induced T cell apoptosis by monocytes from stem cell products

Kessinger, 1991, High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin's disease [published erratum appears in Blood 1991 Dec 15; 78 (12) 3330], Blood, 77, 2322, 10.1182/blood.V77.11.2322.bloodjournal77112322 Vose, 1993, High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma, J. Clin. Oncol., 11, 1846, 10.1200/JCO.1993.11.10.1846 Chao, 1993, Granulocyte colony-stimulating factor “mobilized” peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy, Blood, 81, 2031, 10.1182/blood.V81.8.2031.2031 Roberts, 1993, Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation, Bone Marrow Transplant., 12, 469 Talmadge, 1996, Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation, Bone Marrow Transplant., 17, 101 Mills, 1996, Immunologic phenotype and function in human bone marrow, blood stem cells and umbilical cord blood, Bone Marrow Transplant., 18, 53 Peters, 1996, Antifungal effects of yeast-derived rhu-GM-CSF in patients receiving high-dose chemotherapy given with or without autologous stem cell transplantation: a retrospective analysis, Bone Marrow Transplant., 18, 93 Avigan, 2000, Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer, Bone Marrow Transplant., 26, 169, 10.1038/sj.bmt.1702474 Lin, 2000, Increased apoptosis of peripheral blood T cells following allogeneic hematopoietic cell transplantation, Blood, 95, 3832, 10.1182/blood.V95.12.3832 Brugnoni, 1999, Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death, Bone Marrow Transplant., 23, 451, 10.1038/sj.bmt.1701608 Mackall, 2000, Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults, Blood, 96, 754, 10.1182/blood.V96.2.754 Verfuerth, 2000, Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell-depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire, Blood, 95, 3990, 10.1182/blood.V95.12.3990 Talmadge, 1997, Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow, Bone Marrow Transplant., 19, 161, 10.1038/sj.bmt.1700626 Kiesel, 1989, Autologous peripheral blood stem cell transplantation: analysis of autografted cells and lymphocyte recovery, Transplant Proc., 21, 3084 Scambia, 1993, Immunological reconstitution after high dose chemotherapy and autologous blood stem cell transplantation for advanced ovarian cancer, Eur. J. Cancer., 29A, 1518, 10.1016/0959-8049(93)90286-O Olsen, 1988, Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow support, Transplantation, 46, 57, 10.1097/00007890-198807000-00009 Ino, 1997, Monocytes from mobilized stem cells inhibit T cell function, J. Leukocyte Biol., 61, 583, 10.1002/jlb.61.5.583 Singh, 1999, Fas–FasL-mediated CD4+ T-cell apoptosis following stem cell transplantation, Cancer Res., 59, 3107 Talmadge, 2000, Potential for cytokine and product manipulation to improve the results of autologous transplantation for rheumatoid arthritis, J. Rheumatol. Ageitos, 1997, Restoration of T and NK cell function in GM-CSF mobilized stem cell products from breast cancer patients by monocyte depletion, Bone Marrow Transplant., 20, 117, 10.1038/sj.bmt.1700864 Ageitos, 1998, IL-2 expansion of T and NK cells from growth factor-mobilized peripheral blood stem cell products: monocyte inhibition, J. Immunother., 21, 409, 10.1097/00002371-199811000-00002 Ageitos, 1999, Comparison of monocyte-dependent T cell inhibitory activity in GM-CSF vs. G-CSF mobilized PSC products, Bone Marrow Transplant., 23, 63, 10.1038/sj.bmt.1701524 Ozerol, 1999, Impaired T and NK cell response of bone marrow and peripheral blood stem cell products to interleukin (IL)-2, Int. J. Immunopharmacol., 21, 509, 10.1016/S0192-0561(99)00029-6 Bensinger, 1995, Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor, Blood, 85, 1655, 10.1182/blood.V85.6.1655.bloodjournal8561655 Korbling, 1995, Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts, Blood, 85, 1659, 10.1182/blood.V85.6.1659.bloodjournal8561659 Osborne, 1994, Detection and management of bone marrow micrometastases in breast cancer, Oncology, 8, 25 Segre, 1985, Cyclophosphamide-induced suppressor cells in mice: suppression of the antibody response in vitro and characterization of the effector cells, Cell Immunol., 91, 443, 10.1016/0008-8749(85)90242-4 Hock, 1991, Interleukin 7 induces CD4+ T cell-dependent tumor rejection, J. Exp. Med., 174, 1291, 10.1084/jem.174.6.1291 Talmadge, 1986, Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin-2: contribution of large granular lymphocytes and T lymphocytes, Cell Immunol., 102, 261, 10.1016/0008-8749(86)90420-X Yannelli, 1990, Use of anti-CD3 monoclonal antibody in the generation of effector cells from human solid tumors for use in cancer biotherapy, J. Immunol. Methods, 130, 91, 10.1016/0022-1759(90)90303-D Telford, 1991, Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry, Cell Proliferation, 24, 447, 10.1111/j.1365-2184.1991.tb01173.x Maier, 1986, Natural suppressor (NS) cells, members of the LGL regulatory family, Immunol. Today, 7, 312, 10.1016/0167-5699(86)90069-1 Schmidt-Wolf, 1992, T-cell subsets and suppressor cells in human bone marrow, Blood, 80, 3242, 10.1182/blood.V80.12.3242.3242 Palathumpat, 1992, Studies of CD4-CD8-alpha/beta bone marrow T-cells with suppressor activity, J. Immunol., 148, 373, 10.4049/jimmunol.148.2.373 Noga, 1988, Characterization of natural suppressor cell populations in adult rat bone marrow, J. Leukocyte Biol., 43, 279, 10.1002/jlb.43.3.279 Sykes, 1988, Mechanism of protection from graft-vs.-host disease in murine mixed allogeneic chimeras: I. Development of a null cell population suppressive of cell-mediated lympholysis responses and derived from the syngeneic bone marrow component, J. Immunol., 140, 2903, 10.4049/jimmunol.140.9.2903 Pak, 1995, Mechanisms of immune suppression in patients with head and neck cancer: Presence of immune suppressive CD34+ cells in cancers that secrete granulocyte/macrophage colony-stimulating factor, Clin. Cancer Res., 1, 95 Young, 1990, Stimulation of immune-suppressive bone marrow cells by colony-stimulating factors, Exp. Hematol., 18, 806 Oghiso, 1993, Differential induction of prostaglandin E2-dependent and-independent immune suppressor cells by tumor-derived GM-CSF and M-CSF, J. Leukocyte Biol., 53, 86, 10.1002/jlb.53.1.86 Wanebo, 1988, Indomethacin sensitive suppressor-cell activity in head and neck cancer patients. The role of the adherent mononuclear cell, Cancer, 61, 462, 10.1002/1097-0142(19880201)61:3<462::AID-CNCR2820610310>3.0.CO;2-Z Farinas, 1991, Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer, Cancer, 68, 1279, 10.1002/1097-0142(19910915)68:6<1279::AID-CNCR2820680617>3.0.CO;2-Y Hebib, 1999, Blood, 94, 1803, 10.1182/blood.V94.5.1803 Caligiuri, 1990, Functional consequences of IL-2-receptor expression on resting human lymphocytes: identificaiton of a novel NK-cell sub-set with high-affinity receptors, J. Exp. Med., 171, 1509, 10.1084/jem.171.5.1509 Minami, 1993, The IL-2 receptor complex: its structure, function, and target genes, Annu. Rev. Immunol., 11, 245, 10.1146/annurev.iy.11.040193.001333 Krakauer, 1985, A macrophage-derived factor that inhibits the production and action of interleukin-2, J. Leukocyte Biol., 38, 429, 10.1002/jlb.38.3.429 Schleifer, 1993, Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins, J. Immunol., 151, 5492, 10.4049/jimmunol.151.10.5492 Mills, 1991, Molecular basis of “suppressor” macrophages. Arginine metabolism via the nitric oxide synthetase pathway, J. Immunol., 146, 2719, 10.4049/jimmunol.146.8.2719 Albina, 1991, Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway, J. Immunol., 147, 144, 10.4049/jimmunol.147.1.144 Tomioka, 1995, The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection, J. Leukocyte Biol., 58, 704, 10.1002/jlb.58.6.704 Wu, 1995, Monocytes are required to prime peripheral blood T cells to undergo apoptosis, Proc. Natl. Acad. Sci. U. S. A., 92, 1525, 10.1073/pnas.92.5.1525 Suss, 1996, A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis, J. Exp. Med., 183, 1789, 10.1084/jem.183.4.1789 Munn, 1996, Selective activation-induced apoptosis of peripheral T cells imposed by macrophages: a potential mechanism of antigen-specific peripheral lymphocyte deletion, J. Immunol., 156, 523, 10.4049/jimmunol.156.2.523 Scott, 1996, T cells commit suicide, but B cells are murdered!, J. Immunol., 156, 2352, 10.4049/jimmunol.156.7.2352 Ju, 1995, Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation, Nature, 373, 444, 10.1038/373444a0 Alderson, 1995, Fas ligand mediates activation-induced cell death in human T lymphocytes, J. Exp. Med., 181, 71, 10.1084/jem.181.1.71